Hyperspectral Imaging for Non-invasive Diagnostics of Melanocytic Lesions
John Paoli(Sahlgrenska University Hospital), Noora Neittaanmäki(University of Helsinki), Susanna Juteau(University of Helsinki), Sari Pitkänen(University of Helsinki), Janne Räsänen(Tampere University Hospital), Meri Övermark(University of Helsinki), Mari Salmivuori(Tampere University Hospital), Sari Koskenmies(University of Helsinki), Annamari Ranki(University of Helsinki), Sam Polesie(Sahlgrenska University Hospital), Kirsi Isoherranen(University of Helsinki), M Grönroos(Päijät-Hämeen Keskussairaala), Oscar Zaar(Sahlgrenska University Hospital), Ilkka Pölönen(University of Jyväskylä)
Cited by 12
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Guidelines on the use of extracorporeal photopheresis
|Journal of the European Academy of Dermatology and Venereology|2013|218